Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2009 4
2010 5
2011 4
2012 5
2013 3
2014 6
2015 3
2016 2
2017 5
2018 5
2019 5
2020 8
2021 6
2022 11
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Understanding LAG-3 Signaling.
Chocarro L, Blanco E, Zuazo M, Arasanz H, Bocanegra A, Fernández-Rubio L, Morente P, Fernández-Hinojal G, Echaide M, Garnica M, Ramos P, Vera R, Kochan G, Escors D. Chocarro L, et al. Among authors: kochan g. Int J Mol Sci. 2021 May 17;22(10):5282. doi: 10.3390/ijms22105282. Int J Mol Sci. 2021. PMID: 34067904 Free PMC article. Review.
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Les I, Martínez M, Pérez-Francisco I, Cabero M, Teijeira L, Arrazubi V, Torrego N, Campillo-Calatayud A, Elejalde I, Kochan G, Escors D. Les I, et al. Among authors: kochan g. Cancers (Basel). 2023 Mar 6;15(5):1629. doi: 10.3390/cancers15051629. Cancers (Basel). 2023. PMID: 36900420 Free PMC article. Review.
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
Ortiz-Espinosa S, Morales X, Senent Y, Alignani D, Tavira B, Macaya I, Ruiz B, Moreno H, Remírez A, Sainz C, Rodriguez-Pena A, Oyarbide A, Ariz M, Andueza MP, Valencia K, Teijeira A, Hoehlig K, Vater A, Rolfe B, Woodruff TM, Lopez-Picazo JM, Vicent S, Kochan G, Escors D, Gil-Bazo I, Perez-Gracia JL, Montuenga LM, Lambris JD, Ortiz de Solorzano C, Lecanda F, Ajona D, Pio R. Ortiz-Espinosa S, et al. Among authors: kochan g. Cancer Lett. 2022 Mar 31;529:70-84. doi: 10.1016/j.canlet.2021.12.027. Epub 2021 Dec 28. Cancer Lett. 2022. PMID: 34971753
Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy.
Redondo-Muñoz M, Rodriguez-Baena FJ, Aldaz P, Caballé-Mestres A, Moncho-Amor V, Otaegi-Ugartemendia M, Carrasco-Garcia E, Olias-Arjona A, Lasheras-Otero I, Santamaria E, Bocanegra A, Chocarro L, Grier A, Dzieciatkowska M M, Bigas C, Martin J, Urdiroz-Urricelqui U, Marzo F, Santamaria E, Kochan G, Escors D, Larrayoz IM, Heyn H, D'Alessandro A, Attolini CS, Matheu A, Wellbrock C, Benitah SA, Sanchez-Laorden B, Arozarena I. Redondo-Muñoz M, et al. Among authors: kochan g. Nat Metab. 2023 Sep;5(9):1544-1562. doi: 10.1038/s42255-023-00861-4. Epub 2023 Aug 10. Nat Metab. 2023. PMID: 37563469 Free PMC article.
Cutting-Edge CAR Engineering: Beyond T Cells.
Chocarro L, Blanco E, Fernández-Rubio L, Arasanz H, Bocanegra A, Echaide M, Garnica M, Ramos P, Piñeiro-Hermida S, Vera R, Kochan G, Escors D. Chocarro L, et al. Among authors: kochan g. Biomedicines. 2022 Nov 24;10(12):3035. doi: 10.3390/biomedicines10123035. Biomedicines. 2022. PMID: 36551788 Free PMC article. Review.
PD-L1, a Master Regulator of Immunity 2.0.
Kochan G. Kochan G. Int J Mol Sci. 2023 Feb 23;24(5):4385. doi: 10.3390/ijms24054385. Int J Mol Sci. 2023. PMID: 36901818 Free PMC article.
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.
Escors D, Bocanegra A, Chocarro L, Blanco E, Piñeiro-Hermida S, Garnica M, Fernandez-Rubio L, Vera R, Arasanz H, Kochan G. Escors D, et al. Among authors: kochan g. Int J Mol Sci. 2022 Oct 31;23(21):13241. doi: 10.3390/ijms232113241. Int J Mol Sci. 2022. PMID: 36362027 Free PMC article. Review.
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.
Echaide M, Chocarro de Erauso L, Bocanegra A, Blanco E, Kochan G, Escors D. Echaide M, et al. Among authors: kochan g. Int J Mol Sci. 2023 Mar 21;24(6):5944. doi: 10.3390/ijms24065944. Int J Mol Sci. 2023. PMID: 36983017 Free PMC article. Review.
Hyperprogressive Disease: Main Features and Key Controversies.
Arasanz H, Zuazo M, Bocanegra A, Chocarro L, Blanco E, Martínez M, Morilla I, Fernández G, Teijeira L, Morente P, Echaide M, Castro N, Fernández L, Garnica M, Ramos P, Escors D, Kochan G, Vera R. Arasanz H, et al. Among authors: kochan g. Int J Mol Sci. 2021 Apr 3;22(7):3736. doi: 10.3390/ijms22073736. Int J Mol Sci. 2021. PMID: 33916696 Free PMC article. Review.
Novel immunotherapies for the treatment of melanoma.
Gato-Cañas M, Arasanz H, Blanco-Luquin I, Glaría E, Arteta-Sanchez V, Kochan G, Escors D. Gato-Cañas M, et al. Among authors: kochan g. Immunotherapy. 2016 May;8(5):613-32. doi: 10.2217/imt-2015-0024. Immunotherapy. 2016. PMID: 27140413 Review.
81 results